Novel Immune Cell Engagers for Cancer
9:30 am - Wednesday 24th June 2026
- Exploring strategies for widening the therapeutic index in solid tumors and haematological malignancies
- Development of CD8-biased T cell engagers
- Supporting T cell mediated anti-tumor immunity with CD8-biased IL-2
